🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

✅ Excited to see our work showcased at the plenary session! At #EULAR2025

Self-management of rheum disease is ripe for apps, gamification. How well does it work though? This app (Axia) in axSpA was basically as good as a biologic. Maybe you downplay non-pharm management, prob because we don’t do it well. This changes that #EULAR2025 LB0002 Dr. John Cush

Treatment of relapsing polychondritis #Rheumatology #MedTwitter #EULAR2025

Great to see health inequalities and social determinants of health are having a big presence at #EULAR2025! To address the issue we first need to talk about it “We have a moral, legal and economic duty to act”, as Dr Christopher Marley points out

Climate Change Impacts #Rheumatology Care Taking HEAT 🥵 causes: 🔺️⬆️ Hospitalisations 🔺️Renal failure ⚠️ NSAIDs 🔺️Flooding: no access to healthcare 🔺️New Infectious diseases mimics RMDs: Zika... 🔺️Insecurities for drug storage and transportation #EULAR2025 Dr. John Cush

Prof Loreto Carmona talks about how different factors, like environment and insurance, can impact inflammatory arthritis. #EULAR2025

#EULAR2025 Abstr#POS0301 Real World Multicentre study in Italy reported higher proportion of CRR at 6-mth & Lower GC in people with #lupus nephritis (~96% Class III, IV or Mixed with V) treated with Belimumab+SOC vs matched cohort on SOC. Predicted by early BEL use Dr. John Cush

CONGRESS | #EULAR2025 | POSTER Anca Askanese, Columbia University, presented a post hoc analysis of CARE phase 2 study of cenerimod in pts with #SLE (EX-4mg arm; n=85). Sustained modified SLEDAI-2K score in 63.5% of pts vs 50% with PBO in 12 months. Chance of experiencing a 4-month

Very thoughtful critical appraisal of #SLE guidelines by Laurent ARNAUD at #NEDAI2025 the 🇵🇹 PT autoimmunity congress. A broad range of rapidly growing and evolving guidelines - how do they apply to the patient in front of you? Always thought provoking listening to him!

There's a lot to be said on this newest preprint showing that reliance on LLMs in writing tasks leads to a 'consistent underperformance' in neural and behavioral levels with potential long-term consequences. Interestingly, I think this ties to similar but (early)

Unsurprisingly Cyril Zakka, MD says it better than I could. These are the exact concerns I have about the way we are integrating LLMs into clinical care. It *might* not matter, but we are all participating in an educational Pascal's wager right now. A 🧵🔽

Cyril Zakka, MD Beyond the long-term educational issues, this also really validates the concerns from our NEJM editorial Adam Rodman Arjun (Raj) Manrai. Divorcing reasoning from documentation changes the underlying cognitive process, and we can't assume without evidence that they are equivalent.

I hear interns and residents banally say they had to prioritise due to time limitations so they couldn't do a full note. I see the use of copy-paste. I feel clinical reasoning skills are changing (to put it politely). I fear what might be next. #MedEd needs to adapt at all levels

(0/5) Here are five of the commonest cognitive traps in medicine (and forcing strategies to avoid each)👇

✅ Very happy to report that we have completed STEP 2 of #LUPUSALERT, asking a large international panel to triage & prioritize #lupus #vulnerabilities suggested during step 1, for inclusion in the final screening questionnaire 👍 Thanks to you all for your contributions 👏

🚀 #LupusALERT keeps moving forward! We’re one step closer to a tool that will screen for vulnerabilities people may face during lupus care. A bit thank you to all who contributed!💜 Huge thanks to Laurent ARNAUD & Daniel G. Oliveira for their commitment and dedication!